Genomic Health, Inc. has launched their NoMatterMyAge campaign, focused on raising awareness around age bias in cancer care, including access to genomic tests for breast cancer patients. The campaign highlights key facts and statistics about genomic testing based on SEER data and treatment assumptions in younger and older patients.
The NoMatterMyAge campaign focuses on educating and raising awareness about the need for all breast cancer patients, regardless of age, to get as much information as they can before making a treatment decision. This means having an open conversation with your doctor and asking questions about your care, including whether a genomic test may help determine the best treatment plan for you.
This campaign highlights 3 age groups: under 40, 40-70, and over 70. Patient stories and advocate perspectives also contribute to the discussion on age-bias in cancer care and treatment. NoMatterMyAge encourages patients of all ages to get as much information as they can before making a treatment decision, including whether a genomic test may help patients and their physicians determine the best treatment plan.
Find more information at NoMatterMyAge.org.